Skip to main navigation
LinkedIn Twitter
  • Investors
  • Careers
Outlook Therapeutics, Inc. Logo
  • About
    • Overview
    • Senior Leadership
    • Board of Directors
  • Pipeline
    • ONS-5010 / LYTENAVA™ OVERVIEW
    • ONS-5010 CLINICAL PROGRESS
    • UNMET PATIENT NEEDS
    • REPACKAGED IV BEVACIZUMAB
    • NEW OPHTHALMIC ANTI-VEGF
    • POTENTIAL FIRST-LINE THERAPY
  • News
  • Contact

SEC Filings

Home / Investors / Financial Information / SEC Filings

SEC Filings

Filing date Form Description Filing Group View
Aug 10, 2015 D
Other
View HTML
0001649989-15-000001.rtf
0001649989-15-000001.pdf
Oct 13, 2015 D
Other
View HTML
0001649989-15-000002.rtf
0001649989-15-000002.pdf
Dec 23, 2015 D
Other
View HTML
0001649989-15-000004.rtf
0001649989-15-000004.pdf
Sep 25, 2017 D
Other
View HTML
0001231919-17-000040.rtf
0001231919-17-000040.pdf
Mar 11, 2020 D
Other
View HTML
0001231919-20-000013.rtf
0001231919-20-000013.xls
0001231919-20-000013.pdf
Jun 09, 2020 D
Other
View HTML
0001231919-20-000037.rtf
0001231919-20-000037.xls
0001231919-20-000037.pdf
Feb 12, 2021 D
Other
View HTML
0001231919-21-000017.rtf
0001231919-21-000017.xls
0001231919-21-000017.pdf
Jun 13, 2016 25-NSE

25-NSE

Other
View HTML
0001354457-16-000402.rtf
0001354457-16-000402.pdf
May 16, 2018 25-NSE

25-NSE

Other
View HTML
0001354457-18-000141.rtf
0001354457-18-000141.pdf
Feb 16, 2022 25-NSE

25-NSE

Other
View HTML
0001354457-22-000145.rtf
0001354457-22-000145.xls
0001354457-22-000145.pdf

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 573 results
  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Other Shareholder Information
  • Financial Information
    • SEC Filings
  • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Presentations
  • Corporate Governance
    • Governance Highlights
    • Board Diversity Disclosure
    • Senior Leadership
    • Board of Directors
    • Committee Composition
  • Information Request
  • Print Page Print Page
  • Email Page Email Page
  • RSS Feeds RSS Feeds
  • Email Alerts Email Alerts
  • Contact IR Contact IR
© 2023 Outlook Therapeutics, Inc.
Privacy Policy | Disclaimer